[1] CHEN Y,BOGOSAVLJEVIC V,LEYS D,et al.Intravenous thrombolytic therapy in patients withstroke mimics:baseline characteristics and safetyprofile[J]. Eur J Neurol,2011,18(10):1246-1250.[2] FÖRSTER A,GRIEBE M,WOLF M E,et al. Howto identify stroke mimics in patients eligible forintravenous thrombolysis?[J]. J Neurol,2012,259(7):1347-1353.[3] LEE S W,DONLON S,CAPLAN J P. Steroidresponsive encephalopathy associated withautoimmune thyroiditis(SREAT)or Hashimoto'sencephalopathy:a case and review[J].Psychosomatics,2011,52(2):99-108.[4] SADAN O,SEYMAN E,ASH E L,et al. Adultonsettemporal lobe epilepsy,cognitive decline,multi-antiepileptic drug hypersensitivity,andHashimoto's encephalopathy:two case studies[J/OL].Epilepsy Behav Case Rep,2013,1:132-135[2019-12-10]. https://doi.org/10.1016/j.ebcr.2013.07.004.[5] VISÉE H,MABIGLIA C,VANDERASPOILDENV,et al. Recurrent status epilepticus associated withHashimoto's encephalopathy[J/OL]. Epilepsy BehavCase Rep,2013,1:113-117[2019-12-10]. https://doi.org/10.1016/j.ebcr.2013.06.003.[6] ONESTI E,KOUDRIAVTSEVA T,GALIÈ E,etal. A possible case of Hashimoto's encephalopathyafter surgery and radiometabolic therapy for thyroidcarcinoma[J]. Neurol Sci,2013,34(8):1489-1491.[7] LORENZONI P J,SCOLA R H,KAY C S,etal. MELAS:clinical features,muscle biopsy andmolecular genetics[J]. Arq Neuropsiquiatr,2009,67(3A):668-676.[8] MAEDA K,KAWAI H,SANADA M,et al.Clinical phenotype and segregation of mitochondrial3243A>G mutation in 2 pairs of monozygotictwins[J]. JAMA Neurol,2016,73(8):990-993.[9] THOMPSON A J,BANWELL B L,BARKHOF F,et al. Diagnosis of multiple sclerosis:2017 revisionsof the McDonald criteria[J]. Lancet Neurol,2017,17(2):162-173.[10] LO SASSO B,AGNELLO L,BIVONA G,et al.Cerebrospinal fluid analysis in multiple sclerosisdiagnosis:an update[J]. Medicina(Kaunas),2019,55(6):245.[11] MENÉNDEZ-VALLADARES P,GARCÍASÁNCHEZM I,ADORNA MARTÍNEZ M,etal. Validation and meta-analysis of kappa indexbiomarker in multiple sclerosis diagnosis[J].Autoimmun Rev,2019,18(1):43-49.